omega-n-methylarginine has been researched along with c & b metabond in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (c & b metabond) | Trials (c & b metabond) | Recent Studies (post-2010) (c & b metabond) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 382 | 38 | 68 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikegami, T; Kurane, I; Maeda, A; Morikawa, S; Niikura, M; Saijo, M | 1 |
1 other study(ies) available for omega-n-methylarginine and c & b metabond
| Article | Year |
|---|---|
Modification of endothelial cell functions by Hantaan virus infection: prolonged hyper-permeability induced by TNF-alpha of hantaan virus-infected endothelial cell monolayers.
Topics: Boron Compounds; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Enzyme Inhibitors; Guanidines; Hantaan virus; Humans; Indomethacin; Interleukin-6; Methacrylates; Methylmethacrylates; Nitric Oxide; omega-N-Methylarginine; Permeability; Prostaglandins; Recombinant Proteins; Tumor Necrosis Factor-alpha; Umbilical Veins | 2004 |